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Abstract  15 
Evidence of ecotoxicological effects of active pharmaceuticals ingredients (APIs) has 16 
increased research into their environmental fate. In low and low-middle income countries 17 
(LLMICs) the main source of APIs to surface waters is from discharge of untreated 18 
wastewater. Consequently, concentrations of APIs can be relatively high in the “impact zone” 19 
downstream of a discharge point. Little is known about the fate of APIs in these impact 20 
zones. In this laboratory scale investigation, the effect of successive dilution of synthetic 21 
untreated wastewater (dilution factor 1 to 10) on the distribution of APIs was studied. The 22 
sorption was consistent with the chemical properties of each compound: charge, 23 
lipophilicity, and structure. Dilution increased desorption of the basic and neutral APIs (up to 24 
27.7%) and correlated with their lipophilicity (R2>0.980); the positive charge was of 25 
secondary importance. Anions did not significantly desorb (< 10% loss). Increased 26 
concentrations of dissolved organic matter at dilutions of 8 and 10 times untreated 27 
wastewater coincided with lower API concentrations in solution. The data showed a clear 28 
trend in the desorption process of APIs that may lead to higher exposure risk than 29 
anticipated. Therefore, it is suggested that these aspects should be accounted for in the 30 
development of dedicated environmental risk assessment approach for APIs in riverine 31 
impact zones of LLMICs countries. 32 
Key words: pharmaceuticals, wastewater, partitioning, dissolved organic matter, impact 33 
zone, dilution 34 
Abbreviations: 35 
APIs, active pharmaceutical ingredients  36 
LLMICs, low and low-middle income countries  37 
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DUW, direct discharge of untreated wastewater  38 
DF, dilution factor  39 
CBZ, carbamazepine  40 
ACT, acetaminophen 41 
NVR, nevirapine 42 
DCF, diclofenac 43 
VLS, valsartan 44 
ACE, acebutolol 45 
AMI, amitriptyline  46 
SW, synthetic wastewater  47 
  48 
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1. Introduction 49 
The increasing consumption and production of active pharmaceutical ingredients (APIs) in 50 
low and low-middle income countries (LLMICs) is growing environmental concern owing to 51 
the awareness of possible ecotoxicological effects (Kookana et al., 2014).  This is related to 52 
the diffused practice of direct discharge of untreated wastewater (DUW), the main source of 53 
APIs to the environment, which creates a heavily polluted area downstream from the 54 
discharge point, named the “impact zone”(A.I.S.E./CESIO, 1995; Finnegan et al., 2009; 55 
Kookana et al., 2014; Malik et al., 2015; Nansubuga et al., 2016; Thebo et al., 2017).  56 
Little is known about the environmental fate of APIs in the “impact zone” created by the 57 
DUW. Nevertheless, a few available measured environmental concentrations (MECs) of APIs 58 
in impact zones of LLMICs show higher concentrations than for high-income countries with 59 
developed wastewater treatment infrastructure (Madikizela et al., 2017). For instance, in the 60 
Nairobi River basin, Kenya, APIs were detected in concentrations ranging from ng L-1 to 160 61 
µg L-1 (K’oreje et al., 2016, 2012; Ngumba et al., 2016), in Nigeria, were reported individual 62 
concentrations above 50 µg L-1 (Olatunde et al., 2014), and again, in South Africa were 63 
detected concentrations of atenolol and ibuprofen up to 30 and 85 µg L-1 respectively 64 
(Agunbiade and Moodley, 2015, 2014; Matongo et al., 2015), and antiretroviral were 65 
quantified at concentrations up to hundreds of ng L-1 (Wood et al., 2015). Pharmaceutical 66 
factories wastewater was deemed as the cause of APIs concentrations up to mg L-1 in 67 
Pakistan (Ashfaq et al., 2017) and India (Larsson, 2014); and in tropical Asia, sulphonamides 68 
antibiotics in surface waters were found to be at higher concentrations than in high-income 69 
countries (Shimizu et al., 2013). In one reported case, the environmental risk assessment 70 
showed a potential for risk, and pharmaceutical manufactory wastewater contribution was 71 
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deemed as important, as also evidenced by other investigations (Ashfaq et al., 2017; 72 
Larsson, 2014; Ngumba et al., 2016). Although API manufacturing sites would be expected to 73 
be identified as high risk, it should also be noted that in high income countries direct 74 
discharge of untreated wastewater from such factories is illegal. The reported data for LLMIC 75 
countries therefore highlights the environmental concerns and need for carefully considered 76 
risk assessment.  77 
As demonstrated above, globally there are common occurrences of API concentrations in 78 
“impact zones” which exceed 0.01 µg L-1 for any individual compound.  Under the existing 79 
risk assessment process, if predicted, such a PEC would trigger Phase II of the environmental 80 
risk assessment (ERA) (EMA, 2006), which consists of a two-step tiered protocol to the 81 
evaluation of the risk. Tier A is an initial environmental fate and effects analysis that, if 82 
resulting in a risk, should be followed by Tier B, an extended environmental fate and effects 83 
analysis (EMA, 2006). The latter is a refinement of the predicted environmental 84 
concentration (PEC) in the surface water using a distribution coefficient, which considers the 85 
moiety adsorbed to sewage sorbents as being retained in the wastewater treatment sludge 86 
(OECD, 2000). Equation 1 is used for PEC refinement in tier B of the ERA: 87 
 88 
Where PECsurface water is the output of the local surface water concentration (µg l
-1); Elocalwater 89 
is the local emission to wastewater of the relevant residue (µg l-1); Fstp water is the fraction of 90 
emission directed to wastewater (µg l-1); WASTEWinhab is the amount of wastewater per 91 
inhabitant per day (l d-1); CAPACITYSTP is the capacity of the local wastewater treatment 92 
𝑃𝐸𝐶𝑆𝑈𝑅𝐹𝐴𝐶𝐸 𝑊𝐴𝑇𝐸𝑅 =
𝐸𝑙𝑜𝑐𝑎𝑙𝑤𝑎𝑡𝑒𝑟 ∗ 𝐹𝑠𝑡𝑝 𝑤𝑎𝑡𝑒𝑟
𝑊𝐴𝑆𝑇𝐸𝑊𝑖𝑛ℎ𝑎𝑏 ∗ 𝐶𝐴𝑃𝐴𝐶𝐼𝑇𝑌𝑠𝑡𝑝 ∗ 𝐹𝐴𝐶𝑇𝑂𝑅 ∗ 𝐷𝐼𝐿𝑈𝑇𝐼𝑂𝑁
 1 
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plant (l); FACTOR accounts for adsorption to suspended matter; and DILUTION is the DF, 93 
with a default value of 10 (EMA, 2006).  94 
 Where untreated wastewater is discharged there is little or no retention of sludge, the 95 
entire crude sewage is input to the “impact zone” scenario. Consequently, the sorbents 96 
loaded with APIs are discharged and diluted with the receiving freshwater, and possible 97 
redistribution processes might cause imprecise calculation of PECs and the associated risk 98 
quotient.  99 
Engineering protocols recommended a ratio of river flow to untreated wastewater flow of 40 100 
(DF) (Keller et al., 2014) to allow dilution and dispersion of pollution. A DF of 10 assuming 101 
previous wastewater treatment is used as the default value for environmental risk 102 
assessment (EMA, 2006; European Comission Joint Research Centre, 2003). 103 
Although risk assessments are inherently designed to be conservative, data suggests this 104 
level of dilution may not always be the case. In at least 14 countries worldwide, the local 105 
predicted DF median observations show a value below 10, the majority being in North Africa 106 
and the Middle East, with Belgium as the only European country (Keller et al., 2014). The 107 
number increases to 53 countries worldwide if data of observations falling in the 5 and 25 108 
percentiles are considered (Keller et al., 2014). The APIs sorption processes to wastewater 109 
sorbents control the exposure to biota (Agunbiade and Moodley, 2015; Carmosini and Lee, 110 
2009; Hernandez-Ruiz et al., 2012; Hudson et al., 2007; Lahti and Oikari, 2011; OECD, 2000; 111 
Peng et al., 2014; Svahn and Bjorklund, 2015; Wang et al., 2016; Zhou et al., 2007), and since 112 
DUW occurs at dilutions that can cause significant desorption of APIs (Hajj-Mohamad et al., 113 
2017; Yang et al., 2011) such exposure might be underestimated with simple dilution 114 
calculations.  115 
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The aim of this study was to assess the partitioning of APIs to wastewater sorbents and to 116 
quantify the potential dilution-induced desorption in receiving freshwaters using a 117 
standardised synthetic untreated wastewater diluted across a range of DFs. This approach is 118 
aimed to assess the effect of the major constituents present in untreated wastewater, 119 
particularly the presence of high concentrations of organic carbon, potentially capable of 120 
‘stabilising’ APIs in the dissolved phase, on the environmental fate of APIs. Outcomes of the 121 
study could then be used to inform the development of an improved exposure assessment 122 
approach for a range of contaminants in the impact zone generated by the DUW in 123 
freshwaters.  124 
2. Materials and methods 125 
2.1. Active pharmaceutical ingredients  126 
The APIs were selected to reflect consumption patterns of LLMICs where the DUW occurs 127 
more commonly. Compound structure and chemical functionality were also fundamental 128 
selection criteria due to their fundamental impact on partitioning processes. The selected 129 
compounds are the neutral carbamazepine (CBZ), acetaminophen (ACT), and nevirapine 130 
(NVR), the acidic diclofenac (DCF) and valsartan (VLS), and the basic acebutolol (ACE), and 131 
amitriptyline (AMI) (Table S1 of the Supporting Information). The compounds were obtained 132 
at the highest purity available, either from Sigma-Aldrich (acebutolol hydrochloride, 133 
amitriptyline hydrochloride, nevirapine, valsartan, acetaminophen) or Fisher Scientific 134 
(carbamazepine, diclofenac sodium salt). 135 
2.2. Synthetic wastewater 136 
Wastewater composition is highly variable both within and between wastewater treatment 137 
works (WwTW) particularly in LLMIC countries (Tchobanoglous et al., 2003). It is impossible 138 
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to replicate any given natural matrix within a laboratory setting owing to this inherent 139 
variability. The choice of using ‘natural’ versus synthetic wastewater is an interesting debate 140 
with benefits and drawbacks associated with each approach (O’Flaherty and Gray, 2013). 141 
The purpose of these experiments was to generate a surrogate untreated wastewater with 142 
which to assess the partitioning behaviour of the tested APIs. Consequently, to ensure a 143 
consistent, reproducible and stable starting matrix for testing a synthetic wastewater (SW) 144 
formulation was used (Boeije et al., 1999). The keys aspects of the starting ‘crude’ sewage 145 
matrix were appropriate suspended solids and organic carbon levels and characteristics. The 146 
use of lyophilized primary settled sludge collected from a local WwTW as one of the main 147 
‘ingredients’ provided these bulk characteristics as confirmed by 3-D fluorimetry and Fourier 148 
Transfom Infra-Red analysis, which were shown to be stable for at least 24 hours once made 149 
up.  (see section S1 of the supporting information).  The original constituents were further 150 
concentrated (x 3) to simulate a high strength wastewater as a worst-case scenario 151 
(Tchobanoglous et al., 2003) (S1.2, Table S2). The SW ingredients were mixed with a 152 
polycarbonate stirrer bar in a 2 L volumetric flask. The pH was adjusted to 7.5 with 10 mM 153 
phosphate buffer (monosodium phosphate, monohydrate, 0.026%; Disodium phosphate, 154 
heptahydrate, 0.22%). Sodium azide (NaN3) was added at 0.02% to prevent bacterial growth 155 
(Yamamoto et al., 2009). The formulation involved the addition of dry sewage sludge, which 156 
was collected and lyophilized (Kerr et al., 2000; Stevens-Garmon et al., 2011). Briefly, high 157 
purity water was added to an aliquot of the sample and shaken for 5 minutes. The 158 
suspension was then centrifuged at 4000 rpm for 15 minutes and the supernatant 159 
discarded; this process was repeated three times. The resulting solids were placed in sealed 160 
glass beakers and frozen at -20 ˚C for at least 24 h. Subsequently, the samples were freeze 161 
dried overnight. In order to further reduce the potential for microbiological activity, the 162 
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samples were heated in an oven at 103 ˚C overnight. The procedure was repeated for each 163 
SW synthesis.  164 
The SW was characterized for composition and tested for reproducibility and stability. A 165 
sacrificial sampling system was designed and run for 24 hours at sampling intervals of 0, 0.5, 166 
1, 2, 4, 8, 12, and 24 hours. The SW was characterised using excitation-emission 167 
fluorescence spectrophotometry (F-4500 fluorescence spectrophotometer, Hitachi), 168 
Dissolved Organic Carbon (DOC) analyses (Shimadzu), and Fourier Transmission Infrared 169 
(FTIR) spectrometry (Vertex 70, Bruker) (S1.3). 170 
2.3. Analytical methodology 171 
Suspended solids removal from the wastewater was obtained by 0.7 µm GF/F filters 172 
(Whatman). A solid phase extraction (SPE) method for the selected APIs and SW matrix was 173 
used with the aim of removing the analytes from their complex matrix, improving the 174 
chromatographic separation and mass spectrometric detection and quantification of the 175 
APIs. The protocol followed a previously validated and published method for the multi-176 
residue analysis of pharmaceuticals in wastewater (Vergeynst et al., 2015). The SPE 177 
cartridges, OASIS HLB cartridges (Waters) (200 mg polymeric sorbent; 6 mL barrel volume), 178 
were activated with methanol (Thermo Fisher Scientific, Optima LC/MS) and ultra-high 179 
purity water (UHP) obtained with a MilliQ system (>18.2 MΩcm-1, Merck Millipore) then 180 
loaded with 5 mL of the pre-filtered sample and washed with 1 mL of UHP.  Subsequently, 181 
the compounds were eluted with 5 mL of methanol amended with formic acid (2%). The 182 
eluent was collected in 5 mL HPLC grade vials and evaporated under a gentle nitrogen 183 
stream until dryness. Reconstitution was performed with 1:10 methanol/water. All 184 
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glassware and plastic ware was acid cleaned prior to use (2% v/v Decon, ≥24 h; 10% v/v HCl, 185 
≥24 h; final rinse with UHP).  186 
The chromatographic separation was obtained with a reversed phase column (XBridge BEH 187 
C18 2.5 µm 2.1x50 mm Column XP, Waters) operating at the temperature of 50 °C (Dionex 188 
Ultimate 3000, Thermo Scientific). As aqueous eluent was used UHP with 0.1% formic acid 189 
LC/MS grade as additive (Fisher scientific). Methanol was used as the organic eluent. The 190 
flow rate was set at 500 µL min-1. The elution consisted of a flow gradient of the duration of 191 
5.5 minutes from 100% aqueous to 100% methanol and an aqueous equilibration time of 2.5 192 
minutes. 193 
High-resolution mass spectrometry was performed by means of an orbitrap-based system 194 
(Thermo Scientific). The ionisation source was a Heated Electro-Spray Ionisation (HESI) set as 195 
follow: Sheath gas 53 Arb (nitrogen); Auxiliary gas 14 Arb (nitrogen); Sweep gas 3 Arb 196 
(nitrogen); Vaporiser temperature 300 °C; Polarity Positive and/or negative ion; Spray 197 
voltage (+) 3500/ (-) 2500 V; Capillary temperature 270°C; S-lens RF level 50. The mass 198 
spectrometer detector settings were as follow: Resolution 17,500 m/z 200; Positive polarity; 199 
Scan range full scan m/z 100 -1000; AGC target 1e6 (automatic gain control); Micro scans 1; 200 
Maximum ion time was set as automatic. solution. Mass calibration was achieved in positive 201 
mode with a mixture of caffeine, MRFA, Ultramark 1621 and n-butylamine in 202 
acetonitrile/methanol/acetic solution (Pierce LTQ Velos ESI, Thermo Fisher Scientific). 203 
2.4. Experimental approach 204 
Triplicate SW incubations (500 mL) were spiked with APIs each at a concentration of 100 µg 205 
L-1 as deemed representative for a possible impact zone concentration. This concentration 206 
was chosen for the following reasons (i) it represents levels that can be observed in impact 207 
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zones (ii) levels were not so high as to bias any physico-chemical effects which might occur in 208 
the impact zone and (iii) concentrations were of sufficiently high to allow accurate and 209 
precise determination using the applied analytical technique in the dissolved phase after 210 
equilibration (particularly for the strongly adsorbing APIs). Samples were continually stirred 211 
and progressively diluted using UHP (MilliQ, deionised water resistivity of at least 18.2 212 
MΩ•cm at 25 degrees Celsius). A pH of 7.5 was chosen to be representative of the 213 
environmental and wastewater matrix. Sample blanks and controls were included (Figure 1). 214 
The flasks were wrapped in aluminium foil to avoid exposure to light. The dilution 215 
distribution dynamics were tested over a range of ten dilution factors (DF): 1, 1.2, 1.4, 1.6, 216 
1.8, 2, 2.2, 4, 8, 10. The DFs were based on the progressive achievement of DF 10, which is 217 
the environmental risk assessment default assumption (EMA, 2006; Keller et al., 2014). After 218 
each dilution, the sample was left for 24 hours to reach equilibrium before sampling, which 219 
was a conservative time estimate (Conrad et al., 2006; Yang et al., 2011).  220 
 221 
Figure 1. Experimental design of the dilution experiment. A-B-C were sample replicates; D 222 
was the blank and E was the control where APIs were added to buffered and 223 
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sterilized (NaN3) ultra-high pure water (UHP). Each batch was progressively 224 
diluted with UHP from the dilution factor (DF) 1 to 10 (1, 1.2, 1.4, 1.6, 1.8, 2, 4, 6, 225 
8, 10) along a period of 10 days. 226 
2.5. Calculations 227 
2.5.1. Determination of Kd values 228 
The environmental fate of a contaminant is largely determined by its sorption behaviour. 229 
The extent of sorption is expressed as the distribution coefficient, Kd, normally determined 230 
by the particulate : dissolved ratio at equilibrium (Franco and Trapp, 2008). In this study the 231 
concentration in solids refers to sorption to the bulk sorbents of untreated wastewater, 232 
including colloids and DOM, and therefore hereafter named as concentration in sorbents 233 
(Cs) whilst the concentration in water (Cw) to the freely available fraction.  234 
Therefore, the Kd exp. is obtained from the ratio of the compound concentration in the 235 
sorbent phase (Cs) and in the aqueous phase (Cw) (Equation 2): 236 
𝑲𝒅 =
𝑪𝒔
𝑪𝒘
 2 
The distribution coefficient was calculated at each DF. The modelled distribution coefficient 237 
values (Kd Mod.) were also calculated for comparison to the experimental ones. The pH 238 
dependent octanol-water distribution coefficient (Dow), which accounts for compound 239 
dissociation, dependent on the pKa, was calculated for each compound functionality, 240 
according to Equations 3-5 (neutral, acidic and basic, respectively): 241 
𝐥𝐨𝐠 𝑫𝒐𝒘𝑵 = 𝒍𝒐𝒈𝑲𝒐𝒘 3 
𝒍𝒐𝒈𝑫𝒐𝒘𝑨 = 𝒍𝒐𝒈𝑲𝒐𝒘 + 𝒍𝒐𝒈
𝟏
𝟏 + 𝟏𝟎𝒑𝑯−𝒑𝑲𝒂
 4 
13 
 
𝒍𝒐𝒈𝑫𝒐𝒘𝑩 = 𝒍𝒐𝒈𝑲𝒐𝒘 + 𝒍𝒐𝒈
𝟏
𝟏 + 𝟏𝟎𝒑𝑲𝒂−𝒑𝑯
 5 
Where log Dow is the distribution coefficient octanol-water (log Kow) adjusted to the 242 
dissociation of the compound at a given pH; pKa is the dissociation constant of the 243 
compound (Lin et al., 2010). 244 
Log Dow was related to Kd using Equation 6 (Lin et al., 2010): 245 
𝐥𝐨𝐠 𝑲𝒅 𝑴𝒐𝒅. = 𝟎. 𝟕𝟒 × 𝐥𝐨𝐠 𝑫𝒐𝒘 + 𝟎. 𝟏𝟓 6 
 246 
2.5.2. Variation from theoretical concentration (% VTC) 247 
In order to evaluate the desorption extent for each API, the theoretical concentration was 248 
calculated at each DF, including undiluted sample (DF1), and subtracted from experimental 249 
data. The results were recalculated as the percentage of variation from the theoretical 250 
concentration (%VTC) for normalisation, as shown in Equation 7:  251 
%𝑽𝑻𝑪 = (𝑪𝒆𝒙𝒑 − 𝑪𝒕𝒉 𝑪𝑫𝑭𝟏) × 𝟏𝟎𝟎⁄  7 
Where Cexp is the API experimental concentration in water, Cth is the API theoretical 252 
concentration in water and CDF1 was the API concentration in water at DF 1. 253 
  254 
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3. Results and discussion 255 
3.1. Sorption 256 
The API distribution in undiluted samples (DF 1) is presented in Figure 2 as a percentage of 257 
the compound remaining in solution and ordered per log Kow.  258 
 259 
Figure 2.  Percentage (%) of APIs in solution after spiking at no dilution (DF 1); the 260 
compounds are ordered per increase of API log Kow, as indicated in the top bar. 261 
The error bars show the standard deviation (ACT, acetaminophen; ACE, 262 
acebutolol; NVR, nevirapine; CBZ, carbamazepine; VSL, valsartan; DCF, 263 
diclofenac; AMI, amitriptyline). 264 
These data were used as the initial concentration for the calculation of the theoretical 265 
concentration after dilution and the log Kd (Table 1). 266 
API
ACT ACE NVR CBZ VLS DCF AMI
%
 A
P
I 
in
 s
o
lu
ti
o
n
 a
ft
e
r 
s
o
rp
ti
o
n
0
20
40
60
80
100
120
0.3 1.7 2.5 2.7 3.6 4.3 4.9 
Log K
ow
 
15 
 
Table 1 Measured concentration in undiluted solution (DF1) and experimental solid-water 267 
distribution coefficient values. 268 
DF 1 ACT ACE NVR CBZ VLS DCF AMI 
µg L
-1
 102.39 92.05 73.05 83.68 84.42 91.20 46.58 
Log Kd [L kg
-1
] -1.70 2.27 2.90 2.62 2.60 2.32 3.39 
* ACT, acetaminophen; ACE, acebutolol; NVR, nevirapine; CBZ, carbamazepine; VSL, valsartan; DCF, diclofenac; 269 
AMI, amitriptyline. 270 
At the experimental pH of 7.5, the acidic and basic APIs are calculated to be fully ionised, 271 
and the compounds defined as neutral, ACT (pKa 9.38), NVR (pKa 2.8) and CBZ (pKa 13.2), 272 
may be considered fully unionised. The measured sorption behaviour was consistent with 273 
the chemical properties of each compound: charge, lipophilicity, and structure, and in 274 
accord with previous studies (Jelic et al., 2011; Silva et al., 2011; Verlicchi et al., 2012) 275 
The low log Kow (0.3) of the neutral ACT predicts little sorption, which agrees with previously 276 
published studies (Li et al., 2015; Lin et al., 2010; Martínez-Hernández et al., 2014; OECD, 277 
1997). The neutral CBZ and NVR, log Kow of 2.7 and 2.5 respectively, show a similar sorption 278 
trend. Sorption was greatest for AMI, consistent with its high lipophilicity (log Kow 4.9) and 279 
the influence of the positive charge. In fact, the lipophilic interactions are reported to be 280 
most important, whilst the charge on the ionised functional group exercises a secondary 281 
control on the distribution processes (Franco and Trapp, 2008; Githinji et al., 2011; 282 
Martínez-Hernández et al., 2014; Silva et al., 2011). The low sorption of ACE was supported 283 
by its log Kow (1.7), which confirmed the secondary impact of the positive charge in 284 
determining the sorption behaviour. DCF and VLS, however, adsorbed less strongly than 285 
expected per their relatively high log Kow (3.6 and 4.3, respectively). This was likely due to 286 
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the degree of repulsion of the negative charge on both the API and sorbent competing with 287 
lipophilic attraction (Delle Site, 2001; Paul et al., 2014).  288 
The log Kd obtained at DF1 were compared with values available in the literature (Table 2)  289 
(Al-Khazrajy and Boxall, 2016; Bai et al., 2008; Hernandez-Ruiz et al., 2012; Lahti and Oikari, 290 
2011; Li et al., 2015; Lin et al., 2010; Loffler et al., 2005; Maoz and Chefetz, 2010; Martínez-291 
Hernández et al., 2014; Maskaoui et al., 2007; Maskaoui and Zhou, 2010; Stein et al., 2008; 292 
Svahn and Bjorklund, 2015; Yamamoto et al., 2009; Zhou and Broodbank, 2014). The data 293 
show the importance of the sorbent quality (i.e. protein-like or humic-like organic matter) in 294 
determining the extent of API sorption. Wastewater is mainly composed of proteinaceous 295 
material which binds organic contaminants more weakly than humic-like substances typical 296 
of freshwater (Hernandez-Ruiz et al., 2012; Peng et al., 2014; Wang et al., 2016). The 297 
characterization of the synthetic wastewater used during this study confirmed the 298 
predominance of proteinaceous components (Figure S1) and the Kd exp. were consistent with 299 
its comparative binding strength. In fact, the log Kd of -1.70 L kg
-1 for ACT was in the range of 300 
values obtained for suspended solids (SS) (-2.2 and 0.5) in a simulated sewage system (Hajj-301 
Mohamad et al., 2017). Also, the log Kd for CBZ (2.62 L kg
-1) obtained in this study 302 
corresponded to the value reported by Maoz and Chefetz (Maoz and Chefetz, 2010) for 303 
DOM extracted from bulk sewage sludge (2.64 L kg-1), and in the range obtained by Lahti 304 
and Oikari (Lahti and Oikari, 2011) for sediments from wastewater effluent (2.00-3.42 L kg-305 
1) (Table S3). CBZ sorption to humic-like substances revealed a much larger log Kd in 306 
contrast of up to 6.66 L kg-1 (Table S3). The proteinaceous composition of the SW could 307 
explain the lack of ACE sorption despite the positive charge, consistent with the range (log 308 
Kd of 0.5 - 1.0 L kg
-1) obtained by Lahti and Oikari (Lahti and Oikari, 2011) for particulate 309 
matter derived from wastewater treatment works effluent, considerably less than 3.28 L kg-310 
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1, obtained by Lin et al. for freshwaters, typically characterized by the presence of humic-like 311 
substances (Lin et al., 2010). However, the repulsion of negative charges on the dissociated 312 
acidic compounds is more important in sorption processes than the sorbent quality. This 313 
was shown by the log Kd exp. 2.13 L kg
-1 for DCF obtained for synthetic humic-like suspended 314 
solids by Ra et al. (Ra et al., 2008) that was close to the value of 2.32 L kg1 obtained in this 315 
study (Table 1).   316 
3.2. Trend of dissolved concentration of APIs as a function of 317 
dilution 318 
The variation in concentration of the dissolved APIs with dilution is shown in Figure 3. 319 
Desorption is expressed as the percentage variation from the theoretical concentration 320 
(%VTC) against DF. The extent of the deviation, as a dilution effect, varied between 321 
compounds, determined by the relative influence of compound functionality and 322 
lipophilicity.  323 
Maximum deviation was measured at low DF, namely DF 2, whilst at higher DF the 324 
concentrations of APIs are similar to the theoretical values. The highest %VTC occurred for 325 
AMI (27.7%), followed by CBZ (12.4%), NVR (11.8%), ACE (7.7%), DCF (4.2%), ACT (1.3%), and 326 
VSL (-3.2%). 327 
Figure 3 shows the behaviour of the compounds separated by functionality. The compound 328 
ACT showed no variation from the theoretical concentration at each dilution factor (Figure 329 
3A), which was expected as sorption was insignificant (Figure 3). ACT (pKa 9.38) was neutral 330 
at the experimental pH so functionality would not have influenced sorption. The low log Kow 331 
(0.3 L Kg-1) indicates negligible lipophilicity, consistent with the low retention shown by the 332 
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wastewater sorbents. As such, ACT behaved conservatively at each DF. The neutral 333 
compounds NVR and CBZ show a similar trend of deviation from predicted concentration 334 
(+10 %VTC at DF2). The two APIs were both neutral at the experimental pH and their log Kow 335 
values are similar (2.50 and 2.67 L Kg-1, respectively), which explains the similar trend, and 336 
highlights the role of lipophilicity in controlling the sorption of APIs to and from the 337 
wastewater sorbents. CBZ and NVR have similar molecular structures that could be the 338 
cause of the notable persistence of the former (Andreozzi et al., 2004), and, if true also for 339 
the latter, would help explain the ubiquitous presence of NVR in impact zones (K’oreje et al., 340 
2016, 2012; Ngumba et al., 2016).  341 
Figure 3B shows the trend in the deviation from the theoretical concentration for the basic 342 
compounds AMI and ACE. AMI shows the largest %VTC (27.7%) amongst the compounds 343 
investigated, which is concomitant with the largest log Kow value (4.9). ACE is a cation at the 344 
experimental pH, but the lipophilicity (log Kow 1.7) appeared to be the only physico-chemical 345 
parameter affecting desorption.  346 
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 347 
Figure 3  Percentage of variation from theoretical concentration of A: neutral compounds 348 
acetaminophen (ACT), Nevirapine (NVR), and carbamazepine (CBZ); B: basic 349 
compounds Acebutolol (ACE) and Amitriptyline (AMI); C: acidic compounds 350 
Valsartan (VLS) and Diclofenac (DCF); at DF from 1 to 10. 351 
Figure 3C shows the behaviour of the acidic compounds VLS and DCF. As previously 352 
discussed, these acidic compounds showed little sorption, despite the large log Kow, likely 353 
due to repulsion between the negative charge on the compound and the negative net 354 
charge of the organic matter sorbents (Refaey et al., 2017). Also, little desorption was 355 
measured for DCF (10%VTC) and none for VLS. The former behaviour was likely determined 356 
by strong binding of electrical forces involving charge transfer (~40 kJ mol-1), which regards 357 
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the moiety of negative charged compounds that once adsorbed would be unlikely reversible 358 
(Martínez-Hernández et al., 2014). 359 
Lipophilicity was the main parameter determining the behaviour of the neutral and cationic 360 
APIs, whilst the negative charge on the anionic APIs strongly interfered with the 361 
sorption/desorption processes. This trend is shown in Figure 4A, which depicts the 362 
relationships between log Kow and the %VTC of neutral and cationic APIs, on the right of the 363 
black line, and acidic compounds, on the left. Figure 4B shows the correlation of the %VTC 364 
and the log Kow of the neutral and positively charged compounds with the coefficient of 365 
determination (R2) greater than 0.950 in 7 of the 9 DFs.  366 
 367 
Figure 4  [A] The relationships between the log Kow of neutral and positively charged 368 
APIs on the right of the black line at the percentage of variation from 369 
theoretical concentration (%VTC) of 2, and the lack of relationship of the acidic 370 
compounds, on left side. [B] The correlation of the neutral and positively 371 
charged compounds versus dilution. 372 
3.3. Modelled versus experimental Kd 373 
The log Kd values for the APIs were obtained from experimental data (log Kd exp.) and a 374 
theoretical model (log Kd mod.) (Lin et al., 2010). Additionally, literature solid-water 375 
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distribution coefficients (log Kd lit.) were collected (Table S3), and the upper and lower values 376 
added to Table 2 for comparison. 377 
Although the log Kd mod. at DF 1 did not exactly match the experimental values, the data were 378 
within the range of literature values, which demonstrated the validity of the model (Table 379 
2). The calculated log Kd for AMI was closest to the experimental value (DF 1), but did not 380 
correspond to the literature range of values. However, the log Kd lit. values for AMI originated 381 
from a single study and related to distribution to sediments, whilst the ranges for other 382 
compounds related to more relevant sorbents, namely DOM, colloids and suspended solids. 383 
As previously discussed, the sorbent type and quality strongly affect distribution processes 384 
and, therefore, the Kd values.  385 
Table 2  Modelled (Log Kd mod.), literature values (log Kd lit.), and experimental (Log Kd exp.) 386 
distribution coefficient values for the APIs investigated in this study, including 387 
DFs (Al-Khazrajy and Boxall, 2016; Bai et al., 2008; Hernandez-Ruiz et al., 2012; 388 
Lahti and Oikari, 2011; Li et al., 2015; Lin et al., 2010; Loffler et al., 2005; Maoz 389 
and Chefetz, 2010; Martínez-Hernández et al., 2014; Maskaoui et al., 2007; 390 
Maskaoui and Zhou, 2010; Stein et al., 2008; Svahn and Bjorklund, 2015; 391 
Yamamoto et al., 2009; Zhou and Broodbank, 2014). 392 
Log Kd [L/kg] DF ACT ACE NVR CBZ VLS DCF AMI 
Log Kd mod. / 0.40 1.42 2.00 2.13 2.85 3.15 3.79 
Log Kd lit. / -0.3 - 2.4 0.5 - 3.3 n. a. -1.5 - 6.7 n. a. 0.9 - 6.9 0.9 - 2.4 
Log Kd exp. 1.0 -1.70 2.27 2.90 2.62 2.60 2.32 3.39 
 
1.2 -2.12 0.48 2.78 2.49 2.74 2.08 3.37 
 
1.4 -2.06 0.94 2.82 2.47 2.68 2.42 3.35 
 
1.6 -2.32 2.21 2.76 1.77 2.88 2.06 3.32 
 
1.8 -2.27 2.09 2.75 1.78 3.02 2.21 3.36 
 
2.0 -2.34 2.44 2.65 2.33 3.08 1.61 3.21 
 
2.2 -1.80 2.24 2.73 2.40 3.14 2.19 3.32 
 
4.4 -2.54 2.94 2.32 3.10 3.47 3.04 3.12 
 
8.0 -2.80 2.96 3.57 2.51 4.18 3.56 4.16 
 
10.0 -3.19 2.61 3.39 3.16 4.32 3.57 4.22 
n. a.: not available 393 
A general increase of log Kd occurred at DF 8 and 10 for all APIs, especially NVR, CBZ, VLS and 394 
AMI, where this was up to one order of magnitude (Table 2). These increases were related 395 
with increased concentration of dissolved organic carbon (DOC) at the DF of 8 and 10, as 396 
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depicted by the plot of theoretical and experimental DOC in Figure 5. As the DOC 397 
concentration is a representative measure of the concentration of DOM, it follows that the 398 
dissolution of organic matter from particulate organic matter (POM) increments the cation 399 
exchange capacity because of the increase in specific surface area, and therefore sorption. 400 
Therefore, the decrease of API concentration at the DF of 8 and 10 is likely due to an 401 
interplay of dilution and additional sorption to the proportionally increased DOM, with 402 
respect to the expected concentration from the theoretical calculation. 403 
 404 
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Figure 5  Theoretical and experimental dissolved organic carbon (DOC) concentrations 406 
recorded at each DF; and the increase from theoretical concentration at DF 8 407 
and 10. 408 
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 409 
3.4. Implication of API desorption within the impact zone for ERA  410 
ERA guidelines do not include a protocol for evaluating ecological risk posed by the direct 411 
discharge of API-containing untreated wastewater (EMA, 2006). Although from a human 412 
health and environment point of view such practices should not happen, the fact is that 413 
across LLMIC it is a widespread occurrence. Phase 1 of the ERA guideline is aimed at 414 
estimating exposure within the aquatic environment only. It does not consider the route of 415 
administration, API form, metabolism and excretion. If the PEC is calculated above 0.01 µg l-416 
1, then a phase 2 analysis, which includes the generation of environmental fate and effect 417 
data, should be performed. However, in the phase 2 tier B environmental fate analysis, the 418 
PEC calculation considers the distribution of APIs to the sewage sludge accordingly to the 419 
experimental log Koc, defined as the log Kd value normalized to organic content in sewage 420 
sludge as from the OECD 106 protocol (OECD, 2000).  421 
Equation 1 may not be applicable to discharges of poorly or untreated wastewater where 422 
wastewater treatment is limited or does not occur. In fact, as from the obtained evidence, 423 
highly lipophilic neutral or positively charged APIs desorb more readily with dilution (Figure 424 
4), and omitting desorption could lead to potential underestimation of APIs PEC. Municipal 425 
and industrial wastewater are considered the primary source of APIs to the environment, 426 
while poor or absent wastewater treatment is widespread globally (Malik et al., 2015). This 427 
study has identified clear trends in API environmental cycling during wastewater dilution 428 
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which are not addressed in current APIs environmental risk assessment legislation, and 429 
which could have consequences for the estimation of precise environmental concentrations.  430 
4. Conclusions  431 
Inadequate wastewater treatment and consequent direct discharge of untreated 432 
wastewater to surface waters is a global problem. This study presents data on the sorption 433 
of APIs to untreated wastewater sorbents, and their deviation from theoretical 434 
concentrations during dilution in freshwaters, for the evaluation of exposure 435 
concentrations, using APIs representative of LMICs. 436 
The measured sorption behaviour was consistent with the chemical properties of each 437 
compound: charge, lipophilicity, and structure. ACT was not adsorbed because of its low 438 
lipophilicity and lack of charge, while the behaviour of NVR and CBZ was similar, consistent 439 
with the proximity of their log Kow values and chemical structure. The behaviour of the basic 440 
compounds, AMI and ACE, indicated that primary control of sorption was lipophilicity with a 441 
secondary role for the positively-charged functional group. In contrast, sorption of the acidic 442 
compounds, DCF and VLS, was low due to repulsion between the negatively-charged 443 
compound and the similar net charge on the sorbent surface sites. The measured log Kd 444 
values were consistent with reported values for the types of sorbent studied.  445 
Dilution caused significant positive deviation from theoretical concentrations of the neutral 446 
and basic APIs at low dilution factors, and showed a high correlation to the lipophilicity, with 447 
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the positive charge playing a secondary role. The negatively-charged compounds did not 448 
show significant desorption (i.e. 0 % loss for VLS and < 10 % for DCF). This behaviour was 449 
attributed to irreversible binding of the negatively-charged functional group to positively-450 
charged sites on the sorbent. In addition to dilution, the concomitant increase in DOM 451 
concentration at the higher DF (i.e. 8 and 10) appeared to result in further sorption of APIs.  452 
As a conclusive reflection, the possibility of de-conjugation of conjugates as metabolites 453 
could be summed up to the mechanistic desorption magnitude described in the results. 454 
This study has identified clear trends in API environmental cycling during wastewater 455 
dilution which are not addressed in current APIs environmental risk assessment legislation, 456 
and which could have consequences for the estimation of precise environmental 457 
concentrations. 458 
  459 
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